38
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Comparative CD4 T-Cell Responses of Reverse Transcriptase Inhibitor Therapy With or Without Nelfinavir Matched for Viral Exposure

, , , , , , & show all
Pages 160-170 | Published online: 29 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

A. Castagna, A. Danise, B. Giudici, A. Lazzarin, F. Castelli, G. Paraninfo, G. Carosi & P.L. Carriero. (2002) Long-Term Response in Patients Receiving HAART Including Nelfinavir: Experience from Two Italian Centers. Journal of Chemotherapy 14:2, pages 189-193.
Read now

Articles from other publishers (12)

Vincent C. Marconi, Greg Grandits, Jason F. Okulicz, Glenn Wortmann, Anuradha Ganesan, Nancy Crum-Cianflone, Michael Polis, Michael Landrum, Matthew J. Dolan, Sunil K. Ahuja, Brian Agan & Hemant Kulkarni. (2011) Cumulative Viral Load and Virologic Decay Patterns after Antiretroviral Therapy in HIV-Infected Subjects Influence CD4 Recovery and AIDS. PLoS ONE 6:5, pages e17956.
Crossref
Alba Diaz, Llúcia Alós, Agathe León, Anna Mozos, Miguel Caballero, Antonio Martinez, Montserrat Plana, Teresa Gallart, Cristina Gil, Manuel Leal, Jose M Gatell & Felipe García. (2010) Factors associated with collagen deposition in lymphoid tissue in long-term treated HIV-infected patients. AIDS 24:13, pages 2029-2039.
Crossref
Stacey R. Vlahakis, Steffany A. L. Bennett, Shawn N. Whitehead & Andrew D. Badley. (2007) HIV protease inhibitors modulate apoptosis signaling in vitro and in vivo. Apoptosis 12:5, pages 969-977.
Crossref
Steven G Deeks & Jeffrey N Martin. (2007) Partial treatment interruptions. Current Opinion in HIV and AIDS 2:1, pages 46-55.
Crossref
A D Badley. (2005) In vitro and in vivo effects of HIV protease inhibitors on apoptosis. Cell Death & Differentiation 12:S1, pages 924-931.
Crossref
Joel G.R. Weaver, Agathe Tarze, Tia C. Moffat, Morgane LeBras, Aurelien Deniaud, Catherine Brenner, Gary D. Bren, Mario Y. Morin, Barbara N. Phenix, Li Dong, Susan X. Jiang, Valerie L. Sim, Bogdan Zurakowski, Jessica Lallier, Heather Hardin, Peter Wettstein, Rolf P.G. van Heeswijk, Andre Douen, Romano T. Kroemer, Sheng T. Hou, Steffany A.L. Bennett, David H. Lynch, Guido Kroemer & Andrew D. Badley. (2005) Inhibition of adenine nucleotide translocator pore function and protection against apoptosis in vivo by an HIV protease inhibitor. Journal of Clinical Investigation 115:7, pages 1828-1838.
Crossref
Sonia Molina-Pinelo, Manuel Leal, Natalia Soriano-Sarabia, Sonia Gutiérrez, Gerónimo Fernandez, M Ángeles Muñoz-Fernández, Eduardo Lissen & Alejandro Vallejo. (2005) Prevalence and factors involved in discordant responses to highly active antiretroviral treatment in a closely followed cohort of treatment-naïve HIV-infected patients. Journal of Clinical Virology 33:2, pages 110-115.
Crossref
Ozlem Equils, Alan Shapiro, Zeynep Madak, Chunren Liu & Daning Lu. (2004) Human Immunodeficiency Virus Type 1 Protease Inhibitors Block Toll-Like Receptor 2 (TLR2)- and TLR4-Induced NF-κB Activation. Antimicrobial Agents and Chemotherapy 48:10, pages 3905-3911.
Crossref
J.-D Lelièvre, D Arnoult, F Petit & J Estaquier. (2003) Infection par le VIH1 et apoptose lymphocytaire T CD4. La Revue de Médecine Interne 24:8, pages 522-529.
Crossref
Fernando Dronda, Santiago Moreno, Ana Moreno, José L. Casado, María J. Pérez‐Elías & Antonio Antela. (2002) Long‐Term Outcomes among Antiretroviral‐Naive Human Immunodeficiency Virus–Infected Patients with Small Increases in CD4 + Cell Counts after Successful Virologic Suppression . Clinical Infectious Diseases 35:8, pages 1005-1009.
Crossref
Liam Whitby, Viv Granger, Ian Storie, Karen Goodfellow, Alex Sawle, John T. Reilly & David Barnett. (2002) Quality control of CD4+ T-lymphocyte enumeration: Results from the last 9 years of the United Kingdom national external quality assessment scheme for immune monitoring (1993-2001). Cytometry 50:2, pages 102-110.
Crossref
Barbara N. PhenixJulian J. LumZelin NieJaime Sanchez-DardonAndrew D. Badley. (2001) Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss. Blood 98:4, pages 1078-1085.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.